论文部分内容阅读
Cervical cancer rates are slowly declining in India and it is now the second most common cancer among women.
Opportunities and challenges in cervical cancer prevention in India
【摘 要】
：
Cervical cancer rates are slowly declining in India and it is now the second most common cancer among women.
【机 构】
：
Department of Obstetrics &Gynaecology All India Institute of Medical Sciences New Delhi-110029,India
【出 处】
：
The 6th Biennial Conference of Asia Oceania Research Organis
【发表日期】
：
2014年2期
其他文献
After 10 years since the first clinical trial of the HPV vaccines, new long-term data is now available particularly in the areas of long-term vaccine effectiveness and safety.
会议
Australia and New Zealand (NZ) both have successful organised national cervical screening programs, both established in 1991, which in both countries have resulted in significant reductions in cervica
会议
Whether in clinical trials, prospective cohort studies, or routine screening programs, too many individuals are categorized as "lost to follow-up".How can we prevent the "loss" of these people?
会议
Using science to inform decision making ensures that policies and practices used in the prevention, detection, and treatment of diseases are based on data, principles, and findings.
会议
The Development and Evaluation of a Community Based Model for Cervical Cancer Screening Based on Sel
Objective: To develop and implement a community based model for cervical cancer prevention that allows the communities to manage the screening and the healthcare system to focus resources on evaluatio
会议
El Salvador has one of the worlds highest cervical cancer incidence and mortality rates.To improve cervical cancer screening, the Ministry of Health (MOH), in cooperation with Basic Health Internation
会议
Although HPV vaccination will likely be the ultimate cervical cancer prevention strategy,given its effectiveness, the worldwide familiarity and acceptance of vaccination as a preventive strategy, and
会议
Arbor Vita Corporation, in collaboration with PATH and CICAMS, developed the OncoE6TM Cervical Test ("E6 Test") for settings where ease of test use, short time from sample collection to result, and a
会议
Recent experiences in scaling up HPV vaccination and cervical screening in low-and middle-income cou
The knowledge that cervical neoplasia are caused by persistent infection with one of the high-risk types of human papilloma virus types and around 70％ cervical cancers are caused by HPV 16 or HPV 18 p
会议
Objectives:To describe the experience on scaling up of VIA screening and to assess the diagnosis and management for pre-cancer at BSMMU.